You are viewing a free limited preview of inVentiv Health, Inc.
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
inVentiv Health is a privately-held provider of research, marketing, and consulting services to the healthcare, pharamaceutical, biotech, and life sciences industries. The company's operations are divided into three primary business segments: Clinical, Commercial, and Consulting. The company works with more than 500 healthcare companies around the world with operations in more than 40 countries. In 2010, inVentiv Health was taken private by private equity firm, Thomas H. Lee Partners. The company is headquartered in Burlington, Massachusetts.
| Company Tags: | PE Backed |
| Formerly Named: | Snyder Healthcare Ventiv Health |
| Fiscal Year End: | 12/31 |
| 1YR Revenue Growth Rate: | View % |
| 3YR Revenue Growth Rate (CAGR): | View % |
| 1YR Employee Growth Rate: | View % |
| City: | Burlington |
| State/Province: | Massachusetts |
| Country: | United States |
| Phone: | View |
| Website: | www.inventivhealth.com |
| Parent Companies: | inVentiv Group Holdings, Inc. |
| Subsidiaries: | Adheris Cadent Medical Communications Encuity Research, LLC inServ InsightOut inVentiv Health Selling Solutions inVentiv Medical Management inVentiv Patient Access Solutions Jeffrey Simbrow Associates MedConference MedFocus Smith Hanley Consulting Group, LLC The Navicor Group The Selva Group |
| PICS™: | 7002™, 7004™, 13018™, 700310™, 700316™, 700321™, 700399™, 700803™, 1301107™, 1301128™ |
| NAICS: | View |
| SIC: | View |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All inVentiv Health, Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Income Statement | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
| Revenues | View | View | View | View | View | View | $556,312,000 | $352,184,000 | $224,453,000 | $215,387,000 | $294,763,000 | $274,686,000 | $306,944,000 | $321,500,000 | $208,967,000 |
| Cost of Services | View | View | View | View | $327,648,000 | $241,468,000 | $182,658,000 | $178,901,000 | $260,171,000 | $206,920,000 | $256,297,000 | $236,047,000 | $156,346,000 | ||
| Cost Reimbursable Expenses | View | View | View | View | $89,377,000 | $38,265,000 | |||||||||
| Selling, General and Administrative Expenses | View | View | View | View | $79,313,000 | $38,539,000 | $26,223,000 | $27,397,000 | $32,181,000 | $26,330,000 | $40,451,000 | $43,029,000 | $32,787,000 | ||
| Nonrecurring Charges - Other | $25,569,000 | ||||||||||||||
| Restructuring Charges | $0 | $2,025,000 | $0 | $343,000 | $11,500,000 | ||||||||||
| Merger and Acquisitions Costs | $5,741,000 | $16,164,000 | |||||||||||||
| Impairment of Goodwill | $14,811,000 | $0 | |||||||||||||
| Impairment of Intangible Assets | View | View | View | View | $0 | ||||||||||
| Other Operating Income Expense | ($264,000) | ($392,000) | |||||||||||||
| Operating Expense - Other | $1,900,000 | $0 | |||||||||||||
| Total Operating Expenses excluding costs | View | $496,338,000 | $318,008,000 | $208,489,000 | $206,298,000 | $311,788,000 | |||||||||
| Cost and Operating Expenses | View | View | View | ||||||||||||
| Operating Income/(Loss) | View | View | View | View | $59,974,000 | $34,176,000 | $15,964,000 | $9,089,000 | ($17,025,000) | $41,436,000 | $2,212,000 | $14,760,000 | ($5,735,000) | ||
| Interest Expense | View | View | View | View | $3,955,000 | $922,000 | $549,000 | $1,576,000 | $4,494,000 | $3,024,000 | $360,000 | $2,315,000 | $1,617,000 | ||
| Interest Income | View | View | View | View | $1,409,000 | $678,000 | $413,000 | $456,000 | $427,000 | $826,000 | |||||
| Realized Gains/(Losses) on Sale of Investments | ($2,600,000) | $0 | |||||||||||||
| Gain/(Loss) on Disposition of Property | $0 | $0 | |||||||||||||
| Gain/(Loss) on Disposition of Assets | $0 | ||||||||||||||
| Other Non-operating Asset Related Income | $1,009,000 | $1,850,000 | $568,000 | ||||||||||||
| Income/(Loss) from Continuing Operations Before Income Taxes | $7,969,000 | ($21,092,000) | $39,238,000 | $2,861,000 | $14,295,000 | ($6,784,000) | |||||||||
| Income Loss Continuing Operations Before Income Taxes Minority Interest Earnings Losses Equity Investments | View | $57,428,000 | $33,932,000 | $15,828,000 | |||||||||||
| Income Loss Continuing Operations Before Income Taxes Earnings Loss Equity Investments | View | View | View | ||||||||||||
| Provision for Income Taxes | View | View | View | View | $14,229,000 | $3,802,000 | $5,933,000 | $3,028,000 | ($5,032,000) | $14,523,000 | $3,649,000 | $12,849,000 | $1,934,000 | ||
| Income Loss Continuing Operations Before Minority Interest Earnings Losses Equity Investments | View | $43,199,000 | $30,130,000 | $9,895,000 | |||||||||||
| Minority Interest, Net of Tax Effect | View | View | View | View | $224,000 | $0 | $0 | ||||||||
| Income/(Loss) from Equity Investments | View | View | View | View | $107,000 | $0 | $0 | $0 | |||||||
| Income/(Loss) from Continuing Operations | View | View | View | View | $43,082,000 | $30,130,000 | $9,895,000 | $4,941,000 | ($16,060,000) | $24,715,000 | ($788,000) | ||||
| Income/(Loss) from Discontinued Operations | ($4,092,000) | ($4,772,000) | ($40,488,000) | ($7,901,000) | ($6,004,000) | ||||||||||
| Tax Effect of Income/(Loss) from Discontinued Operations | ($4,379,000) | ($5,400,000) | $0 | $0 | |||||||||||
| Income/(Loss) from Discontinued Operations, Net of Tax Effect | $781,000 | $1,002,000 | ($4,119,000) | $2,951,000 | ($42,442,000) | ($7,901,000) | ($6,004,000) | ||||||||
| Income/(Loss) from Disposition of Discontinued Operations | View | View | View | View | $781,000 | $1,002,000 | ($4,406,000) | $2,323,000 | ($1,954,000) | $0 | $0 | ||||
| Total Income/(Loss) from Discontinued Operations, Net of Tax Effect | View | View | View | View | |||||||||||
| Net Income (Loss) | View | View | View | View | $43,863,000 | $31,132,000 | $5,776,000 | $7,892,000 | ($58,502,000) | $16,814,000 | ($6,792,000) | $1,446,000 | ($8,718,000) |
| Balance Sheet | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
| Cash and Cash Equivalents | View | View | View | View | $73,102,000 | $50,809,000 | $54,970,000 | $46,059,000 | $35,427,000 | $28,395,000 | $37,627,000 | $25,664,000 |
| Current Marketable Securities | $1,898,000 | $0 | ||||||||||
| Current Restricted Cash | View | View | View | View | $3,878,000 | $2,488,000 | $1,672,000 | $1,694,000 | $1,025,000 | |||
| Net Accounts Receivable Trade | View | View | View | View | $112,782,000 | $56,534,000 | $41,836,000 | $28,696,000 | $38,481,000 | $50,631,000 | $51,158,000 | $43,521,000 |
| Current Unbilled Receivables, Net | View | View | View | View | $41,206,000 | $36,130,000 | $21,347,000 | $14,547,000 | $42,480,000 | $15,234,000 | $13,430,000 | $15,212,000 |
| Net Income Taxes Receivable | View | View | View | |||||||||
| Current Deferred Income Taxes | View | View | View | View | $4,029,000 | $8,226,000 | $1,660,000 | $1,744,000 | $956,000 | $0 | $683,000 | |
| Prepaid Expenses | View | View | View | View | $5,737,000 | $2,755,000 | $1,146,000 | $1,426,000 | $1,048,000 | |||
| Current Assets Held-for-Sale | $10,511,000 | $50,925,000 | $17,551,000 | |||||||||
| Current Other Assets | $8,286,000 | $7,568,000 | $10,369,000 | |||||||||
| Current Assets | View | View | View | View | $240,734,000 | $156,942,000 | $122,631,000 | $104,677,000 | $170,342,000 | $120,097,000 | $111,681,000 | $95,449,000 |
| Net Property, Plant and Equipment | View | View | View | View | $36,637,000 | $40,226,000 | $31,457,000 | $19,675,000 | $30,542,000 | $31,989,000 | $14,742,000 | $10,028,000 |
| Investment in Affiliates | View | View | View | |||||||||
| Other Long Term Investments | View | $5,183,000 | $0 | |||||||||
| Goodwill | View | View | View | View | $173,777,000 | $64,823,000 | $20,638,000 | $20,638,000 | $20,638,000 | |||
| Intangible Assets - Other | View | View | View | View | $117,606,000 | $21,370,000 | $85,000 | |||||
| Net Intangible Assets | $89,102,000 | $95,816,000 | $80,728,000 | |||||||||
| Noncurrent Deferred Tax Assets | View | View | View | $3,428,000 | $3,583,000 | $5,438,000 | $7,670,000 | $10,208,000 | $6,559,000 | $9,732,000 | $3,414,000 | |
| Deposits Assets Noncurrent | View | View | View | View | $6,529,000 | $508,000 | $459,000 | $758,000 | $613,000 | $3,467,000 | $1,293,000 | $4,025,000 |
| Assets | View | View | View | View | $583,894,000 | $287,452,000 | $180,708,000 | $153,418,000 | $232,343,000 | $251,214,000 | $233,264,000 | $193,644,000 |
| Accounts Payable | $5,791,000 | |||||||||||
| Accrued Salaries | $13,989,000 | |||||||||||
| Employee Related Liabilities | View | View | ||||||||||
| Other Accrued Expenses | $40,613,000 | |||||||||||
| Accounts Payable and Accrued Expenses | View | View | $77,816,000 | $56,076,000 | $32,105,000 | $28,179,000 | $34,922,000 | $38,390,000 | $53,854,000 | |||
| Current Deferred Income Tax Liabilities | $1,382,000 | $0 | ||||||||||
| Current Deferred/(Unearned) Revenue | $8,446,000 | |||||||||||
| Current Customer Advances | View | View | View | View | $29,393,000 | $9,184,000 | $4,859,000 | $3,725,000 | $16,429,000 | $13,296,000 | $32,406,000 | $1,965,000 |
| Income Taxes Payable | View | View | View | View | $7,359,000 | $12,113,000 | $9,165,000 | $3,279,000 | $5,532,000 | |||
| Current Line of Credit | $35,000,000 | $198,000 | ||||||||||
| Current Portion of Long-Term Debt | View | View | View | View | $1,750,000 | $0 | $2,020,000 | $91,000 | $0 | |||
| Current Capital Lease Obligations | View | View | View | View | $10,859,000 | $12,004,000 | $8,100,000 | $4,148,000 | $8,516,000 | $5,824,000 | ||
| Current Liabilities Held for Sale | $8,537,000 | $27,654,000 | $8,843,000 | |||||||||
| Current Liabilities | View | View | View | View | $127,177,000 | $89,377,000 | $54,229,000 | $47,868,000 | $128,053,000 | $69,755,000 | $86,351,000 | $71,002,000 |
| Long-Term Debt | View | View | View | View | $172,813,000 | $0 | $17,336,000 | $1,155,000 | $1,473,000 | |||
| Capital Lease Obligations - Long-Term | View | View | View | View | $17,695,000 | $24,898,000 | $18,488,000 | $8,904,000 | $16,947,000 | $14,877,000 | $5,000 | |
| Noncurrent Amounts Due To Affiliates | $119,727,000 | |||||||||||
| Minority Interest | View | View | View | View | ($4,000) | $0 | ||||||
| Deferred Tax Liability | View | View | $0 | |||||||||
| Income Taxes Payable Noncurrent | View | View | View | View | ||||||||
| Noncurrent Other Liabilities | View | View | View | View | $12,994,000 | $733,000 | $266,000 | $200,000 | $137,000 | $120,000 | $1,442,000 | |
| Liabilities | View | View | View | View | $330,679,000 | $115,008,000 | $72,983,000 | $56,972,000 | $145,137,000 | $102,088,000 | ||
| Preferred Stock - Value (Excluding Additional Paid in Capital) | View | View | View | View | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock - Value (Excluding Additional Paid in Capital) | View | View | View | View | $28,000 | $26,000 | $23,000 | $23,000 | $23,000 | $23,000 | $25,000 | $0 |
| Additional Paid in Capital | View | View | View | View | $233,441,000 | $193,061,000 | $159,359,000 | $158,619,000 | $157,864,000 | $156,410,000 | $176,495,000 | $0 |
| Retained Earnings | View | View | View | View | $23,092,000 | ($20,543,000) | ($51,675,000) | ($57,451,000) | ($65,343,000) | ($3,026,000) | ($19,840,000) | $0 |
| Treasury Stock - Value | $4,307,000 | $0 | ||||||||||
| Other Accumulated Comprehensive Income, Net of Tax Effect | View | View | View | View | $221,000 | $320,000 | $103,000 | ($4,288,000) | ($4,063,000) | ($1,542,000) | ($2,401,000) | $0 |
| Deferred Compensation | $3,563,000 | $420,000 | $85,000 | $457,000 | $1,275,000 | $2,739,000 | $4,219,000 | $0 | ||||
| Stockholders' Equity | View | View | View | View | $253,219,000 | $172,444,000 | $107,725,000 | $96,446,000 | $87,206,000 | $149,126,000 | $145,753,000 | $0 |
| Liabilities and Stockholders' Equity | View | View | View | View | $583,894,000 | $287,452,000 | $180,708,000 | $153,418,000 | $232,343,000 | $251,214,000 | $233,264,000 | $193,644,000 |
| Cash Flow Statement | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
| Operating Activities Beginning Net Income | View | View | View | View | $43,863,000 | $31,132,000 | $9,895,000 | $7,892,000 | ($58,502,000) | $16,814,000 | ($6,792,000) | $1,446,000 | ($8,718,000) |
| Depreciation (Non-Production) | View | View | View | View | $15,491,000 | $15,602,000 | $9,485,000 | $9,585,000 | $11,881,000 | $6,873,000 | $3,075,000 | $2,150,000 | |
| Amortization | View | View | View | View | $1,934,000 | $306,000 | $19,000 | $47,000 | $1,644,000 | $2,011,000 | $4,361,000 | $3,209,000 | |
| Depreciation and Amortization | $2,169,000 | ||||||||||||
| Employee Stock Option Plan (ESOP) and Restricted Stock Expense | $2,181,000 | $2,173,000 | $0 | ||||||||||
| Asset Impairment Charges | View | View | View | View | $0 | $14,811,000 | $0 | $0 | |||||
| Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment | $392,000 | $0 | ($193,000) | ($982,000) | ($888,000) | ($151,000) | |||||||
| Adjustments to Gain/(Loss) on Sale of Business | $0 | ||||||||||||
| Tax Benefit from Exercise of Stock Options | View | View | View | View | ($9,772,000) | ($4,493,000) | ($345,000) | $166,000 | |||||
| Adjustment Issuance Stock and or Warrants | $5,736,000 | $0 | $0 | ||||||||||
| Adjustment for Equity Based Compensation Expense | View | View | View | View | $694,000 | $138,000 | $397,000 | $518,000 | $725,000 | $954,000 | |||
| Adjustment Write Off of Asset | $500,000 | $0 | $0 | ||||||||||
| Adjustment Write Off of Intangible Asset Excluding Goodwill | View | View | View | ||||||||||
| Adjustment Write Off of Other | $314,000 | $0 | $0 | ||||||||||
| Adjustment Derivatives | View | View | View | View | ($269,000) | $0 | $0 | ($2,400,000) | $6,100,000 | $0 | $0 | ||
| Adjustments to Gains/(Losses) on Sale of Investments | View | View | View | $2,600,000 | $0 | ||||||||
| Adjustment Minority Interest | View | $224,000 | $0 | $0 | |||||||||
| Adjustment Realized Gains Losses On Sale Asset | $0 | $371,000 | |||||||||||
| Adjustment Income/(Loss) from Equity Investments | View | View | View | View | $107,000 | $0 | $0 | $0 | |||||
| Deferred Income Taxes | View | View | View | View | $4,352,000 | ($4,711,000) | $2,316,000 | $1,750,000 | ($732,000) | ($767,000) | ($5,635,000) | $1,324,000 | ($3,914,000) |
| Income/(Loss) from Discontinued Operations, Net of Tax Effect | View | View | View | View | $781,000 | $1,002,000 | $2,951,000 | ($42,442,000) | ($7,901,000) | ($6,004,000) | |||
| Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease) | ($185,000) | $0 | $0 | $126,000 | |||||||||
| Noncash Expenses - Other | ($934,000) | ||||||||||||
| Change Accounts Receivable | View | View | View | View | $20,204,000 | $1,186,000 | $13,140,000 | ($9,785,000) | $960,000 | $13,227,000 | $2,586,000 | $1,040,000 | $7,043,000 |
| Change Unbilled Receivables | View | View | View | View | ($10,348,000) | $9,522,000 | $6,800,000 | ($27,933,000) | $28,439,000 | $3,556,000 | ($1,798,000) | $8,443,000 | $3,074,000 |
| Increase/(Decrease) in Other Current Assets | $669,000 | ($213,000) | ($1,314,000) | ||||||||||
| Change Deposit Other Assets | ($187,000) | $3,533,000 | $1,066,000 | ||||||||||
| Change Prepaid Expenses Other Current Assets | View | View | View | View | ($6,521,000) | $1,208,000 | ($280,000) | ($447,000) | $332,000 | ($488,000) | |||
| Increase/(Decrease) in Other Non-operating Assets | $0 | ||||||||||||
| Increase/(Decrease) in Accounts Payable and Accrued Expenses | View | ($6,401,000) | $8,413,000 | $3,926,000 | ($4,343,000) | $4,647,000 | ($2,006,000) | ($12,466,000) | $8,599,000 | $16,385,000 | |||
| Change Customer Advance | View | View | View | View | ($8,186,000) | $4,286,000 | $1,134,000 | ($12,704,000) | $10,375,000 | ($11,718,000) | ($6,570,000) | $0 | |
| Increase/(Decrease) in Unearned Premiums | $2,586,000 | ||||||||||||
| Increase/(Decrease) in Income Taxes Payable | View | ($4,754,000) | $2,948,000 | $5,886,000 | ($2,253,000) | $4,150,000 | $1,013,000 | ||||||
| Increase/(Decrease) in Employee Related Liabilities | View | View | View | ||||||||||
| Increase/(Decrease) in Customer Deposits | $18,205,000 | ||||||||||||
| Change Income Taxes Receivable and Payables Net | View | View | View | ||||||||||
| Net Other Increase/(Decrease) in Working Capital | View | View | View | View | ($3,757,000) | ($397,000) | ($341,000) | ($63,000) | ($222,000) | ($189,000) | ($2,870,000) | $813,000 | |
| Net Cash Flows Provided By/(Used In) Operating Activities of Discontinued Operations | View | View | View | View | ($951,000) | ($1,125,000) | $2,879,000 | ||||||
| Net Cash Flows Provided By/(Used In) Operating Activities | View | View | View | View | $55,303,000 | $48,961,000 | $16,386,000 | $33,348,000 | $11,038,000 | $5,951,000 | $17,826,000 | ($1,221,000) | ($1,924,000) |
| Purchase of Property, Plant and Equipment | View | View | View | View | $5,936,000 | $5,697,000 | $3,642,000 | $3,966,000 | $4,502,000 | $4,993,000 | $6,683,000 | $4,916,000 | $2,127,000 |
| Purchase Interest in Consolidated Subsidiaries | $1,134,000 | $10,386,000 | $0 | ||||||||||
| Purchase Interest in Unconsolidated Affiliates | View | View | View | ||||||||||
| Purchase Equity Investments | $115,000 | $0 | $0 | $100,000 | $2,500,000 | $0 | |||||||
| Purchase of Other Investments | $0 | ||||||||||||
| Proceeds Sale Marketable Securities | View | View | View | ||||||||||
| Increase/(Decrease) Investments Affiliate | View | ||||||||||||
| Increase Decrease Restricted Funds | View | View | View | View | $1,332,000 | $816,000 | ($22,000) | ||||||
| Acquisition of Businesses, Net of Cash Acquired | View | View | View | View | $187,002,000 | $44,943,000 | $0 | $0 | |||||
| Net Other Acquisition/(Divestiture) of Business Activities | View | View | View | View | |||||||||
| Cash Acquired From Acquisition | $2,916,000 | $6,083,000 | $452,000 | ||||||||||
| Purchases and Payments for Other Investments | ($5,181,000) | $0 | $0 | ||||||||||
| Increase Decrease Marketable Securities | View | ($2,010,000) | $1,262,000 | $2,274,000 | |||||||||
| Purchase Intangible Assets | $347,000 | $3,012,000 | $13,000 | $4,359,000 | |||||||||
| Purchase of Life Insurance Policies | View | $1,382,000 | $0 | $0 | |||||||||
| Total Increase Decrease Life Insurance Policies | View | View | View | ||||||||||
| Proceeds from Discontinued Operations | $17,870,000 | $0 | $0 | ||||||||||
| Proceeds from Sale of Other Assets | $0 | ||||||||||||
| Purchase of Other Assets | $0 | ||||||||||||
| Proceeds from Sale of Property, Plant and Equipment | $1,099,000 | $0 | $0 | $0 | $780,000 | $184,000 | |||||||
| Net Other Investing Activities | View | View | View | View | ($3,093,000) | ($3,799,000) | ($1,478,000) | ($111,000) | ($1,730,000) | ($1,342,000) | $0 | ||
| Net Cash Flows Provided By/(Used In) Investing Activities of Discontinued Operations | View | View | View | View | $1,732,000 | $2,141,000 | $1,280,000 | ||||||
| Net Cash Flows Provided By/(Used In) Investing Activities | View | View | View | View | ($196,123,000) | ($45,516,000) | $237,000 | $14,015,000 | ($2,872,000) | ($6,498,000) | ($9,923,000) | ($7,190,000) | ($3,576,000) |
| Proceeds from Lines of Credit | View | View | View | View | $175,000,000 | $0 | $0 | $16,000,000 | |||||
| Repayments on Lines of Credit | View | View | View | View | $437,000 | $0 | $0 | $35,000,000 | $0 | ||||
| Loans to employee stock ownership Plans | $500,000 | $0 | $0 | ||||||||||
| Net Change Line Credit | View | View | View | $19,000,000 | ($162,000) | $20,603,000 | |||||||
| Proceeds from Related Party Debt | $10,000,000 | ||||||||||||
| Reduction of Capital Lease Obligations | View | View | View | View | $14,624,000 | $11,021,000 | $6,354,000 | $7,274,000 | $7,809,000 | $3,509,000 | $0 | $0 | |
| Repayments on Mortgage Debt | $1,697,000 | ||||||||||||
| Repayments of Related Party Debt | $10,000,000 | ||||||||||||
| Other Repayments of Long Term Debt | $1,838,000 | ||||||||||||
| Net Change Long Term Debt | ($26,917,000) | ||||||||||||
| Excess Tax Benefit Stock Option Exercised | View | View | View | View | $0 | $0 | |||||||
| Debt Issuance Costs | View | $3,330,000 | $0 | $0 | |||||||||
| Financing Costs | $610,000 | $0 | $0 | ||||||||||
| Proceeds from Stock Options Exercised | View | View | View | View | $6,831,000 | $3,198,000 | $555,000 | $0 | $2,351,000 | $1,357,000 | $0 | $0 | |
| Repurchase of Common Stock | $17,585,000 | $4,307,000 | $0 | $0 | |||||||||
| Repurchase Redeemable Preferred Stock | $2,147,000 | ||||||||||||
| Payment of Dividends - Minority Interest | View | View | View | View | $228,000 | $0 | $0 | ||||||
| Contributions from - Affiliates | $14,847,000 | $42,753,000 | ($167,000) | ||||||||||
| Cash Provided by/(Used in) Financing Activities - Other | View | View | View | View | $0 | $0 | $0 | $0 | |||||
| Net Cash Flows Provided By/(Used In) Financing Activities of Discontinued Operations | View | View | View | View | $0 | $0 | $0 | ||||||
| Net Cash Flows Provided By/(Used In) Financing Activities | View | View | View | View | $163,212,000 | ($7,823,000) | ($5,799,000) | ($42,884,000) | $10,542,000 | ($737,000) | $8,181,000 | $15,836,000 | $16,451,000 |
| Total Net Cash Flows Provided By Used In Discontinued Operations | $6,378,000 | $2,853,000 | ($4,080,000) | ($4,182,000) | |||||||||
| Effect of Exchange Rate on Cash and Cash Equivalents | View | View | View | View | ($99,000) | $217,000 | ($1,913,000) | ($225,000) | ($2,521,000) | $1,298,000 | ($1,023,000) | $199,000 | ($177,000) |
| Increase/(Decrease) in Cash and Cash Equivalents | View | View | View | View | $22,293,000 | ($4,161,000) | $8,911,000 | $10,632,000 | $19,040,000 | ($4,066,000) | $10,879,000 | $7,624,000 | $10,774,000 |
| Cash and cash equivalents at the beginning of the year | View | View | View | View | $50,809,000 | $54,970,000 | $46,059,000 | $35,427,000 | $16,387,000 | $20,453,000 | $25,529,000 | $18,040,000 | $7,266,000 |
| Total Cash and cash equivalents at the end of the year | View | View | View | View | $73,102,000 | $50,809,000 | $54,970,000 | $46,059,000 | $35,427,000 | $16,387,000 | $36,408,000 | $25,664,000 | $18,040,000 |
| Income Taxes Paid | View | View | View | View | $5,296,000 | $1,641,000 | $462,000 | $564,000 | $808,000 | $11,962,000 | $7,256,000 | $2,542,000 | $1,550,000 |
| Cash Interest Expense | View | View | View | View | $4,090,000 | $857,000 | $352,000 | $1,312,000 | $2,883,000 | $2,579,000 | $384,000 | $1,526,000 | $899,000 |
| Supplemental Property Plant Equipment Acquired | View | $10,845,000 | $16,581,000 | $19,463,000 | $7,099,000 | $17,129,000 | $24,192,000 | $0 | $0 | ||||
| Stock Issued | View | View | View | View | $19,506,000 | $25,541,000 | $0 | $0 | |||||
| Supplemental Other Net | View | View | View | $0 | $16,336,000 | $64,546,000 | $13,320,000 |
| Financial Notes: | |
| * | inVentiv Health, Inc. fiscal year end: 12/31 |
Export All inVentiv Health, Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide AccessinVentiv Health, Inc. Revenues ($ MM): |
inVentiv Health, Inc. Cost of Services ($ MM): |
inVentiv Health, Inc. Cost Reimbursable Expenses ($ MM): |
inVentiv Health, Inc. Selling, General and Administrative Expenses ($ MM): |
inVentiv Health, Inc. Impairment of Intangible Assets ($ MM): |
inVentiv Health, Inc. Total Operating Expenses excluding costs ($ MM): |
inVentiv Health, Inc. Cost and Operating Expenses ($ MM): |
inVentiv Health, Inc. Operating Income/(Loss) ($ MM): |
inVentiv Health, Inc. Interest Expense ($ MM): |
inVentiv Health, Inc. Interest Income ($ MM): |
inVentiv Health, Inc. Income Loss Continuing Operations Before Income Taxes Minority Interest Earnings Losses Equity Investments ($ MM): |
inVentiv Health, Inc. Income Loss Continuing Operations Before Income Taxes Earnings Loss Equity Investments ($ MM): |
inVentiv Health, Inc. Provision for Income Taxes ($ MM): |
inVentiv Health, Inc. Income Loss Continuing Operations Before Minority Interest Earnings Losses Equity Investments ($ MM): |
inVentiv Health, Inc. Minority Interest, Net of Tax Effect ($ MM): |
inVentiv Health, Inc. Income/(Loss) from Equity Investments ($): |
inVentiv Health, Inc. Income/(Loss) from Continuing Operations ($ MM): |
inVentiv Health, Inc. Income/(Loss) from Disposition of Discontinued Operations ($ MM): |
inVentiv Health, Inc. Total Income/(Loss) from Discontinued Operations, Net of Tax Effect ($ MM): |
inVentiv Health, Inc. Net Income (Loss) ($ MM): |
inVentiv Health, Inc. Cash and Cash Equivalents ($ MM): |
inVentiv Health, Inc. Current Restricted Cash ($ MM): |
inVentiv Health, Inc. Net Accounts Receivable Trade ($ MM): |
inVentiv Health, Inc. Current Unbilled Receivables, Net ($ MM): |
inVentiv Health, Inc. Net Income Taxes Receivable ($ MM): |
inVentiv Health, Inc. Current Deferred Income Taxes ($ MM): |
inVentiv Health, Inc. Prepaid Expenses ($ MM): |
inVentiv Health, Inc. Current Assets ($ MM): |
inVentiv Health, Inc. Net Property, Plant and Equipment ($ MM): |
inVentiv Health, Inc. Investment in Affiliates ($ MM): |
inVentiv Health, Inc. Other Long Term Investments ($ MM): |
inVentiv Health, Inc. Goodwill ($ MM): |
inVentiv Health, Inc. Intangible Assets - Other ($ MM): |
inVentiv Health, Inc. Noncurrent Deferred Tax Assets ($ MM): |
inVentiv Health, Inc. Deposits Assets Noncurrent ($ MM): |
inVentiv Health, Inc. Assets ($ MM): |
inVentiv Health, Inc. Employee Related Liabilities ($ MM): |
inVentiv Health, Inc. Accounts Payable and Accrued Expenses ($ MM): |
inVentiv Health, Inc. Current Customer Advances ($ MM): |
inVentiv Health, Inc. Income Taxes Payable ($ MM): |
inVentiv Health, Inc. Current Portion of Long-Term Debt ($ MM): |
inVentiv Health, Inc. Current Capital Lease Obligations ($ MM): |
inVentiv Health, Inc. Current Liabilities ($ MM): |
inVentiv Health, Inc. Long-Term Debt ($ MM): |
inVentiv Health, Inc. Capital Lease Obligations - Long-Term ($ MM): |
inVentiv Health, Inc. Minority Interest ($): |
inVentiv Health, Inc. Deferred Tax Liability ($ MM): |
inVentiv Health, Inc. Income Taxes Payable Noncurrent ($ MM): |
inVentiv Health, Inc. Noncurrent Other Liabilities ($ MM): |
inVentiv Health, Inc. Liabilities ($ MM): |
inVentiv Health, Inc. Common Stock - Value (Excluding Additional Paid in Capital) ($): |
inVentiv Health, Inc. Additional Paid in Capital ($ MM): |
inVentiv Health, Inc. Retained Earnings ($ MM): |
inVentiv Health, Inc. Other Accumulated Comprehensive Income, Net of Tax Effect ($ MM): |
inVentiv Health, Inc. Stockholders' Equity ($ MM): |
inVentiv Health, Inc. Liabilities and Stockholders' Equity ($ MM): |
inVentiv Health, Inc. Operating Activities Beginning Net Income ($ MM): |
inVentiv Health, Inc. Depreciation (Non-Production) ($ MM): |
inVentiv Health, Inc. Amortization ($ MM): |
inVentiv Health, Inc. Asset Impairment Charges ($ MM): |
inVentiv Health, Inc. Tax Benefit from Exercise of Stock Options ($ MM): |
inVentiv Health, Inc. Adjustment for Equity Based Compensation Expense ($ MM): |
inVentiv Health, Inc. Adjustment Write Off of Intangible Asset Excluding Goodwill ($): |
inVentiv Health, Inc. Adjustment Derivatives ($ MM): |
inVentiv Health, Inc. Adjustments to Gains/(Losses) on Sale of Investments ($ MM): |
inVentiv Health, Inc. Adjustment Minority Interest ($ MM): |
inVentiv Health, Inc. Adjustment Income/(Loss) from Equity Investments ($): |
inVentiv Health, Inc. Deferred Income Taxes ($ MM): |
inVentiv Health, Inc. Income/(Loss) from Discontinued Operations, Net of Tax Effect ($ MM): |
inVentiv Health, Inc. Change Accounts Receivable ($ MM): |
inVentiv Health, Inc. Change Unbilled Receivables ($ MM): |
inVentiv Health, Inc. Change Prepaid Expenses Other Current Assets ($ MM): |
inVentiv Health, Inc. Increase/(Decrease) in Accounts Payable and Accrued Expenses ($ MM): |
inVentiv Health, Inc. Change Customer Advance ($ MM): |
inVentiv Health, Inc. Increase/(Decrease) in Income Taxes Payable ($ MM): |
inVentiv Health, Inc. Increase/(Decrease) in Employee Related Liabilities ($ MM): |
inVentiv Health, Inc. Change Income Taxes Receivable and Payables Net ($ MM): |
inVentiv Health, Inc. Net Other Increase/(Decrease) in Working Capital ($ MM): |
inVentiv Health, Inc. Net Cash Flows Provided By/(Used In) Operating Activities of Discontinued Operations ($ MM): |
inVentiv Health, Inc. Net Cash Flows Provided By/(Used In) Operating Activities ($ MM): |
inVentiv Health, Inc. Purchase of Property, Plant and Equipment ($ MM): |
inVentiv Health, Inc. Purchase Interest in Unconsolidated Affiliates ($ MM): |
inVentiv Health, Inc. Proceeds Sale Marketable Securities ($ MM): |
inVentiv Health, Inc. Increase Decrease Restricted Funds ($ MM): |
inVentiv Health, Inc. Acquisition of Businesses, Net of Cash Acquired ($ MM): |
inVentiv Health, Inc. Net Other Acquisition/(Divestiture) of Business Activities ($ MM): |
inVentiv Health, Inc. Increase Decrease Marketable Securities ($ MM): |
inVentiv Health, Inc. Purchase of Life Insurance Policies ($ MM): |
inVentiv Health, Inc. Total Increase Decrease Life Insurance Policies ($ MM): |
inVentiv Health, Inc. Net Other Investing Activities ($ MM): |
inVentiv Health, Inc. Net Cash Flows Provided By/(Used In) Investing Activities of Discontinued Operations ($ MM): |
inVentiv Health, Inc. Net Cash Flows Provided By/(Used In) Investing Activities ($ MM): |
inVentiv Health, Inc. Proceeds from Lines of Credit ($ MM): |
inVentiv Health, Inc. Repayments on Lines of Credit ($ MM): |
inVentiv Health, Inc. Net Change Line Credit ($ MM): |
inVentiv Health, Inc. Reduction of Capital Lease Obligations ($ MM): |
inVentiv Health, Inc. Excess Tax Benefit Stock Option Exercised ($ MM): |
inVentiv Health, Inc. Debt Issuance Costs ($ MM): |
inVentiv Health, Inc. Proceeds from Stock Options Exercised ($ MM): |
inVentiv Health, Inc. Payment of Dividends - Minority Interest ($ MM): |
inVentiv Health, Inc. Cash Provided by/(Used in) Financing Activities - Other ($ MM): |
inVentiv Health, Inc. Net Cash Flows Provided By/(Used In) Financing Activities ($ MM): |
inVentiv Health, Inc. Effect of Exchange Rate on Cash and Cash Equivalents ($ MM): |
inVentiv Health, Inc. Increase/(Decrease) in Cash and Cash Equivalents ($ MM): |
inVentiv Health, Inc. Cash and cash equivalents at the beginning of the year ($ MM): |
inVentiv Health, Inc. Total Cash and cash equivalents at the end of the year ($ MM): |
inVentiv Health, Inc. Income Taxes Paid ($ MM): |
inVentiv Health, Inc. Cash Interest Expense ($ MM): |
inVentiv Health, Inc. Supplemental Property Plant Equipment Acquired ($ MM): |
inVentiv Health, Inc. Stock Issued ($ MM): |
inVentiv Health, Inc. Supplemental Other Net ($ MM): |
inVentiv Health, Inc. Total Employees: |
inVentiv Health, Inc. Productivity (Revenue/Employee) ($): |
inVentiv Health, Inc. U.S. Revenues ($ MM): |
Export Financials to Excel
$99 Single Company AccessInstant Full Site-Wide Access| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Oct. 2005 | Completed | inChord Communications, Inc.1 | inVentiv Health, Inc. | Acquisition | $193,800,000 |
| Details | Apr. 2006 | Completed | View | View | Acquisition | View |
| Details | Apr. 2006 | Completed | View | View | Acquisition | View |
| Details | Feb. 2007 | Completed | View | View | Acquisition | View |
| Details | Feb. 2007 | Completed | View2 | View | Acquisition | View |
| Details | Jun. 2007 | Completed | View3 | View | Acquisition | View |
| Details | Jun. 2007 | Completed | View4 | View | Acquisition | View |
| Details | Aug. 2008 | View | View | Acquisition | View | |
| Details | Dec. 2009 | Completed | View | View | Acquisition | View |
| Details | May. 2010 | Completed | View | View | Acquisition Leveraged Buyout (LBO) Take Private | View |
| Details | Feb. 2011 | Completed | View | View | Acquisition | View |
| Details | Jun. 2011 | Completed | View5 | View | Acquisition Asset Sale | View |
| Details | Jul. 2011 | Completed | View6 | View | Acquisition Add-On | View |
| Details | Mar. 2012 | Completed | View | View | Acquisition Direct Share Purchase | View |
| Details | Mar. 2012 | Completed | View | View | Asset Sale | View |
| Details | Jun. 2012 | Completed | View7 | View | Acquisition | View |
| Details | Mar. 2013 | Completed | View | View | Acquisition Add-On | View |
| Details | Apr. 2013 | Completed | View | View | Acquisition Asset Sale | View |
| 1 | The transaction was financed using a combination of $177.2 million in cash plus $12.5 million in VTIV common stock. The terms of the transaction also included an earn-out provision contingent on meeting specified financial targets during 2005 through 2007. - Details → |
| 2 | Under the terms of the...Read More → |
| 3 | The acquisition of Addison Whitney...Read More → |
| 4 | InVentiv Health acquired Chandler Chicco...Read More → |
| 5 | The seller, Ingenix, is...Read More → |
| 6 | JLL Partners has sold its...Read More → |
| 7 | The acquisition of Kazaam Interactive...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide Access| Date | Deal Type | Action | Resulting Status | Valuation | Amount Raised | Public Ticker | |
| Details | May. 2010 | View | View | View | View | View | View |
$99 Single Company AccessInstant Full Site-Wide AccessinVentiv Health is a leading global provider of research, marketing and consulting services to the healthcare, pharmaceutical, biotech, and life science industries. inVentiv Health’s global services include clinical development (CRO), selling solutions (CSO), medical education, marketing, communications, public relations, advertising, digital strategy, and management consulting.
The company’s operations and services are divided into three primary business segments: Clinical, Commercial, and Consulting.
Clinical
Commercial
Consulting
$99 Single Company AccessInstant Full Site-Wide Access|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,402 |
| Private Investors | 12,095 |
| Private M&A Deals | 43,310 |
| VC/Funding Rounds | 36,248 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of inVentiv Health, Inc.
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report
